ArticleNPJ vaccines2025

Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza vaccine with bacterial cell membrane-derived adjuvants.

Kirill Vasilev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.